Shares of CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report) traded down 5.3% during trading on Monday . The company traded as low as C$27.00 and last traded at C$27.00. 52,208 shares changed hands during mid-day trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Stock Performance
The firm has a 50-day moving average of C$27.00.
About CanniMed Therapeutics
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Further Reading
- Five stocks we like better than CanniMed Therapeutics
- 3 Monster Growth Stocks to Buy Now
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Investing in Construction Stocks
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
